Chargement en cours...
The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
Hodgkin Lymphoma (HL) is a unique disease entity both in its pathology and the young patient population that it primarily affects. Although cure rates are high, survivorship can be linked with significant long-term morbidity associated with both chemotherapy and radiotherapy. The most significant re...
Enregistré dans:
| Publié dans: | Cancers (Basel) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6025119/ https://ncbi.nlm.nih.gov/pubmed/29914088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10060204 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|